Nanotrap® Magnetic Virus Particles

Nanotrap Magnetic Virus Particles concentrate SARS-CoV-21,2 from wastewater samples without ultracentrifugation or filtration.

  • Capture and concentrate whole virus from wastewater samples.
  • Compatible with RT-qPCR, RT-ddPCR and sequencing based analysis methods.
  • Replace filtration and ultracentrifugation methods, without sacrificing assay sensitivity.
Nanotrap® Magnetic Virus Particles Product

For Research Use Only. Not for use in diagnostic procedures.

Features

  • Nanotrap Magnetic Virus Particles are designed to capture and concentrate a variety of viruses.
  • Nanotrap Magnetic Virus Particles offer a simple and rapid approach for concentration of SARS-CoV-2 from large volume wastewater samples.
  • Nanotrap particles utilize affinity capture and enrichment technology to bind low abundance targets.
  • Wastewater processing protocols available for manual or automated workflows.

Benefits

 

Traditional Wastewater Processing Method

Traditional methods for processing virus from wastewater samples require multiple time-consuming and laborious steps which severely limit throughput.

Traditional wastewater processing method

High-Throughput Wastewater Processing Method with Nanotrap® Particles

Nanotrap Magnetic Virus Particles rapidly capture and concentrate viruses from raw sewage, requiring no filtration or ultracentrifugation. Automated and manual methods available.

Automated method enables 96 raw sewage samples to be processed in 4.5 h (concentration to RT-qPCR detection/quantification), reducing the processing time by at least 20-fold.

High throughput wastewater processing method with nanotrap particles

Nanotrap Magnetic Virus Particles Wastewater Extraction Kit Compatibility

Extraction Kit Vendor Name

Extraction Kit Product Name

Extraction Kit SKU

Nanotrap Enhancement Reagent Compatibility

Nanotrap Particle Manual Protocol

Nanotrap Particle KingFisher System Automated Protocol

Protocol Provided

Magnetic Separator

Applied Biosystems™

MagMax™ Microbiome Ultra Nucleic Acid Isolation Kit

A42357

ER1

APP-029

APP-30

M, A

15 mL, 1.5 mL - Manual

Applied Biosystems™

MagMax™ Viral/Pathogen Nucleic Acid Isolation Kit

A42352

ER1

APP-029

APP-30

M, A

15 mL, 1.5 mL - Manual

Applied Biosystems™

MagMax™ Viral/Pathogen II (MVP II) Nucleic Acid Isolation Kit

A48383

ER1

APP-029

APP-30

M, A

15 mL, 1.5 mL - Manual

Macherey-Nagel

NucleoMag® DNA/RNA Water Kit for water and air samples

744220.1

ER1

APP-31

APP-32

M, A

15 mL, 1.5 mL - Manual

Zymo

ZymoBIOMICS MagBead DNA/RNA

R2135

ER2

APP-40

APP-41

Promega

Maxwell® HT Environmental TNA Kit, Custom

AX9190

ER2

APP-36

APP-37

QIAGEN

MagAttract® Viral RNA Kit (960)

955538

ER2

APP-35

QIAGEN

QIAamp® Viral RNA Mini Kit (250)

52906

ER2

APP-34

QIAGEN

AllPrep® PowerViral® DNA/RNA Kit (50)

28000-50

ER2

APP-33

IDEXX

Water DNA/RNA Magnetic Bead Kit

98-0014719-00

ER2

APP-38

APP-39

Magnetic Separator
DynaMag™-15
DynaMag™-2

Automation
ThermoFisher KingFisher™ Apex System or Flex System

M=Manual
A=Automated

DescriptionCatalog Number
 
Nanotrap Magnetic Virus Particles 10 mL Vial250068
Nanotrap Magnetic Virus Particles 30 mL Vial250069
Nanotrap Enhancement Reagent 1 (ER 1) 10 mL250070
Nanotrap Enhancement Reagent 2 (ER2) 10 mL250071
Nanotrap Enhancement Reagent 1 (ER1) 30 mL250072
Nanotrap Enhancement Reagent 2 (ER2) 30 mL250073

 

Order Nanotrap Magnetic Virus Particles today

New customers

Existing customers

International customers find a distributor

Molecular Diagnostics (MDx) are the tests and techniques that have been developed in recent decades that analyze biological markers such as nucleic acids and proteins, to diagnose and monitor disease, detect disease risks and to monitor the effectiveness of treatments. MDx assays are used in prenatal testing, infectious disease testing, cancer and inherited diseases testing.

Streck ARM-D Kits

The latest from the blog

Molecular

Sepsis in LTC facilities

Governor Pete Ricketts has proclaimed September as Sepsis Awareness Month in the State of Nebraska. The proclamation, signed and sealed on August 19, …
Read More
COVID-19 molecule
Molecular

COVID-19 reverses AR progress

Recently the Centers for Disease Control and Prevention (CDC), issued a press release illustrating the great progress that the health care systems in …
Read More
MDx-Chex for BCID2 meets all requirements
Molecular

New IQCP template for MDx assays

A distinguished group of scientific organizations has revised the microbiology Individualized Quality Control Plan (IQCP) templates and created the fi…
Read More